Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sutter Rock Capital Corp (NQ: SSSS )

5.030 -0.020 (-0.40%)
Streaming Delayed Price Updated: 1:54 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 120,250
Open 5.140
Bid (Size) 5.030 (9)
Ask (Size) 5.070 (8)
Prev. Close 5.050
Today's Range 5.010 - 5.260
52wk Range 3.320 - 5.440
Shares Outstanding N/A
Dividend Yield 19.88%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SuRo Capital (NASDAQ: SSSS) Allows The Everyday Investor Opportunities In Potentially High Growth Startups Like OpenAI And CoreWeave
SuRo Capital (NASDAQ: SSSS) Allows The Everyday Investor Opportunities In Potentially High Growth Startups Like OpenAI And CoreWeave 
Via News Direct
SuRo Capital Corp. Reports Third Quarter 2024 Financial Results
From SuRo Capital Corp.
Via GlobeNewswire

Performance

YTD
+24.81%
+24.81%
1 Month
+10.07%
+10.07%
3 Month
+29.64%
+29.64%
6 Month
+20.62%
+20.62%
1 Year
+27.02%
+27.02%

More News

Read More
SuRo Capital Corp. to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024
From SuRo Capital Corp.
Via GlobeNewswire
Recap: SuRo Capital Q4 Earnings
Via Benzinga
Earnings Outlook For SuRo Capital
Via Benzinga
SuRo Capital: Unlocking Access To Potentially High-Growth Venture Opportunities Like OpenAI And Liquid Death
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence
SuRo Capital Corp. Third Quarter 2024 Preliminary Investment Portfolio Update
From SuRo Capital Corp.
Via GlobeNewswire
SuRo Capital Corp. Reports Second Quarter 2024 Financial Results
From SuRo Capital Corp.
Via GlobeNewswire
SuRo Capital Corp. to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
From SuRo Capital Corp.
Via GlobeNewswire
SuRo Capital Corp. Second Quarter 2024 Preliminary Investment Portfolio Update
From SuRo Capital Corp.
Via GlobeNewswire
SSSS Stock Earnings: SuRo Capital Misses EPS for Q1 2024
Via InvestorPlace
SuRo Capital Corp. Reports First Quarter 2024 Financial Results
From SuRo Capital Corp.
Via GlobeNewswire
SuRo Capital Corp. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
From SuRo Capital Corp.
Via GlobeNewswire
Destiny Tech100: Why I Wouldn’t Touch DXYZ Stock With a 10-Foot Pole
Via InvestorPlace
SuRo Capital Corp. First Quarter 2024 Preliminary Investment Portfolio Update
From SuRo Capital Corp.
Via GlobeNewswire
SuRo Capital Corp. Announces Expiration and Final Results of Tender Offer
From SuRo Capital Corp.
Via GlobeNewswire
SuRo Capital Corp. Tender Offer Expiring on April 1, 2024 at 5:00 P.M., Eastern Time
From SuRo Capital Corp.
Via GlobeNewswire
SuRo Capital Corp. Reports Fourth Quarter and Fiscal Year 2023 Financial Results
From SuRo Capital Corp.
Via GlobeNewswire
Liquid Death Drinks In New Funding At $1.4B Valuation: Investor Anthony Pompliano Calls 'Putting Water In A Can' One Of His 'Best Investments'
Via Benzinga
Earnings Scheduled For March 13, 2024
Via Benzinga
SuRo Capital Corp. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on Wednesday, March 13, 2024
From SuRo Capital Corp.
Via GlobeNewswire
7 Penny Stocks to Buy Before They Pop 7,000%
Via InvestorPlace
SuRo Capital Corp. Will Commence a Modified Dutch Auction Tender Offer to Repurchase up to 2 Million Shares of its Common Stock
From SuRo Capital Corp.
Via GlobeNewswire
SuRo Capital Corp. Fourth Quarter and Fiscal Year 2023 Preliminary Investment Portfolio Update
From SuRo Capital Corp.
Via GlobeNewswire
SuRo Capital Corp. Reports Third Quarter 2023 Financial Results
From SuRo Capital Corp.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.